Literature DB >> 15171696

Role of leukemia inhibitor factor (LIF) in decidualisation of murine uterine stromal cells in vitro.

A A Fouladi Nashta1, C V Andreu, N Nijjar, J K Heath, S J Kimber.   

Abstract

Decidualisation of uterine stromal cells is a prerequisite for implantation of the embryo in mice. Here we have used an in vitro culture system in which stromal cells decidualise as indicated by a number of markers, including an increase in alkaline phosphatase (ALP) activity. The latter was used as a quantitative marker of decidualisation in the presence of low (2%) fetal calf serum. Prostaglandin E(2) (PGE(2)), which is known to induce decidualisation, increased ALP activity, and this effect was blocked in a dose-dependent manner by indomethacin. Leukemia inhibitory factor (LIF) was then examined, but it had no effect on PGE(2) secretion. However, LIF suppressed ALP activity in a dose-dependent manner in the presence of 2% serum, while an inhibitor of LIF that competes for binding to its receptor reversed the effect of LIF and increased ALP activity above the control level. In serum-free cultures, stromal cells differentiated rapidly, and no differences were observed between LIF-treated and untreated cultures. Stromal cells produce LIF during in vitro culture, and this peaked at 48 h. Freshly collected stromal cells from both day-2 and -4 pregnant mice expressed mRNA for the LIF receptor, and the transcript level was higher in cells isolated on day 4. However, no differences were observed in the relative levels of transcripts in cells from day 2 and day 4 after culture, nor were there differences between the LIF-treated cultures and controls. Therefore, in this study, we have shown that LIF suppresses decidualisation of murine uterine stromal cells in the presence of serum, this is not due to the regulation of PGE(2) secretion by stromal cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15171696     DOI: 10.1677/joe.0.1810477

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  6 in total

1.  Activation of the epithelial Na+ channel triggers prostaglandin E₂ release and production required for embryo implantation.

Authors:  Ye Chun Ruan; Jing Hui Guo; Xinmei Liu; Runju Zhang; Lai Ling Tsang; Jian Da Dong; Hui Chen; Mei Kuen Yu; Xiaohua Jiang; Xiao Hu Zhang; Kin Lam Fok; Yiu Wa Chung; Hefeng Huang; Wen Liang Zhou; Hsiao Chang Chan
Journal:  Nat Med       Date:  2012-07       Impact factor: 53.440

2.  Genetic reduction of embryonic leukemia-inhibitory factor production rescues placentation in SOCS3-null embryos but does not prevent inflammatory disease.

Authors:  Lorraine Robb; Kristy Boyle; Steven Rakar; Lynne Hartley; Janelle Lochland; Andrew W Roberts; Warren S Alexander; Donald Metcalf
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-28       Impact factor: 11.205

3.  Egr1 protein acts downstream of estrogen-leukemia inhibitory factor (LIF)-STAT3 pathway and plays a role during implantation through targeting Wnt4.

Authors:  Xiao-Huan Liang; Wen-Bo Deng; Ming Li; Zhen-Ao Zhao; Tong-Song Wang; Xu-Hui Feng; Yu-Jing Cao; En-Kui Duan; Zeng-Ming Yang
Journal:  J Biol Chem       Date:  2014-07-10       Impact factor: 5.157

4.  Leukemia inhibitory factor enhances endometrial stromal cell decidualization in humans and mice.

Authors:  Lorraine Lin Shuya; Ellen Melaleuca Menkhorst; Joanne Yap; Priscilla Li; Natalie Lane; Evdokia Dimitriadis
Journal:  PLoS One       Date:  2011-09-23       Impact factor: 3.240

Review 5.  Trophoblast-uterine interactions at implantation.

Authors:  John D Aplin; Susan J Kimber
Journal:  Reprod Biol Endocrinol       Date:  2004-07-05       Impact factor: 5.211

6.  Expression of mmu-miR-96 in the endometrium during early pregnancy and its regulatory effects on stromal cell apoptosis via Bcl2.

Authors:  Yuan Yang; Yi Xie; Mengyun Wu; Yanqing Geng; Rong Li; Lei Xu; Xueqing Liu; Yongquan Pan
Journal:  Mol Med Rep       Date:  2017-02-17       Impact factor: 2.952

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.